DOCUSATE SODIUM AND SENNOSIDES
docusate sodium and sennosides tablet |
| Product Information |
| Product Type | HUMAN OTC DRUG | Item Code (Source) | NDC: 62993-0002 |
| Route of Administration | ORAL |
|
| Active Ingredient/Active Moiety |
| Ingredient Name | Basis of Strength | Strength |
| DOCUSATE SODIUM (UNII: F05Q2T2JA0) (DOCUSATE - UNII:M7P27195AG) | DOCUSATE SODIUM | 50 mg |
| SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) | SENNOSIDES | 8.6 mg |
|
|
|
| Product Characteristics |
| Color | orange | Score | no score |
| Shape | ROUND | Size | 10mm |
| Flavor | | Imprint Code | |
| Contains | |
|
| Packaging |
| # | Item Code | Package Description | Marketing Start Date | Marketing End Date |
| 1 | NDC: 62993-0002-1 | 30 in 1 BOTTLE; Type 0: Not a Combination Product | 10/01/2025 | |
| 2 | NDC: 62993-0002-2 | 60 in 1 BOTTLE; Type 0: Not a Combination Product | 10/01/2025 | |
| 3 | NDC: 62993-0002-3 | 100 in 1 BOTTLE; Type 0: Not a Combination Product | 10/01/2025 | |
| 4 | NDC: 62993-0002-4 | 1000 in 1 BOTTLE; Type 0: Not a Combination Product | 10/01/2025 | |
| 5 | NDC: 62993-0002-5 | 3000 in 1 BOTTLE; Type 0: Not a Combination Product | 10/01/2025 | |
|
|
| Marketing Information |
| Marketing Category | Application Number or Monograph Citation | Marketing Start Date | Marketing End Date |
| OTC Monograph Drug | M007 | 10/01/2025 | |
|